Study Group 6
Jump to Agenda
Duration 3 hours
Online Zoom meeting
Earn 3 CPD credits
Included with Pro
Book this session
6:00 PM – 9:00 PM (GMT+00:00)
Online
Book this session
Book this session
9:00 AM – 12:00 PM (GMT+00:00)
Online
Book this session
Book this session
6:00 PM – 9:00 PM (GMT+01:00)
Online
Book this session
Book this session
9:00 AM – 12:00 PM (GMT+01:00)
Online
Book this session
Book this session
6:00 PM – 9:00 PM (GMT+01:00)
Online
Book this session
Book this session
9:00 AM – 12:00 PM (GMT+01:00)
Online
Book this session
Book this session
6:00 PM – 9:00 PM (GMT+00:00)
Online
Book this session
Book this session
9:00 AM – 12:00 PM (GMT+00:00)
Online
Book this session
Here, we will examine factors to consider when stopping antidepressants, with a discussion of linear vs proportional tapers. This session will also cover how to differentiate between withdrawal symptoms and a relapse of mental health symptoms.
This session will review the causes of vitamin B12 deficiency and when it is appropriate to test. Furthermore, we will examine the management of vitamin B12 deficiency, including a discussion on oral vs intramuscular therapy.
This session will offer a review of the causes of dry eye syndrome, a discussion about preservative toxicity and a review of primary care treatment options and indications for referral.
This session will cover the initial assessment of the patient presenting with diplopia, including red flags and findings that require immediate onward referral. It will also include a review of the visual standards for driving in a patient with diplopia.
This session will highlight the importance of early recognition of dementia and its profound impact on patients and their families. It will review the role of intervention and support, both within the home and in collaboration with carers, as well as evolving approaches to care. The discussion will include the effects of dementia on family dynamics and mental health, alongside an exploration of current diagnostic pathways and treatment options.
Frailty will be defined and differentiated from normal ageing, with a focus on how to assess it effectively. The session will explore the impact of frailty on the whole patient, considering its implications for care in ageing populations. Prevention and management strategies will be discussed, with an emphasis on the importance of early recognition.
Polypharmacy and its effects on the elderly, including adverse drug reactions and its impact on quality of life, will be explained. The discussion will highlight the importance of regular medication reviews and appropriate discontinuation, addressing the challenges of deprescribing in a prescribing-focused culture. Common scenarios and case studies will be reviewed, showcasing how deprescribing can significantly improve patient care.
Places
To ensure sessions remain sufficiently interactive and educationally rewarding, places will be strictly limited to 30 users per event on a first-come, first-served basis.
Delivered via Zoom
Study groups will be delivered via the Zoom online video platform available for desktop computers (webcam required) or mobile devices. It is important to sign-up to Zoom in advance of the session.